BioSpace News Archive

Catalyst Pharmaceuticals, Inc. today announced the appointment of Molly Harper to the Company’s Board of Directors.

RELIEF THERAPEUTICS Holding AG announced that it has signed and closed the definitive agreement to acquire all outstanding shares of APR Applied Pharma Research S.A., a privately held Swiss pharmaceutical company with over 25 years’ experience in identifying, developing and commercializing known molecules engineered with drug delivery systems in niche and rare diseases on a global basis.

SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company, announced that it has raised SEK 106 million in a Series A2 financing from both existing and new investors.

CN Bio, a leading Organ-on-a-chip Company that designs and manufactures single and multi-organ microphysiological systems, announced that King’s College London, an internationally renowned research university, has adopted the PhysioMimix™ Multi-Organ MPS.

Avacta Group plc is pleased to announce that a study has shown that the AffiDX antigen lateral flow test detects the Delta variant of the SARS-CoV-2 virus in clinical samples and, in this small study, outperformed two lateral flow antigen tests that are commercially available in Europe.

Pardes Biosciences, Inc., an early-stage biopharmaceutical company, and FS Development Corp. II, a special purpose acquisition company sponsored by Foresite Capital, announced they have entered into a definitive merger agreement.

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, announced that Yuichi Iwaki, MD, PhD, President and Chief Executive Officer, and Geoffrey O’Brien, JD/MBA, Vice President and Executive Officer, will present a corporate overview at the Ladenburg Thalmann 2021 Virtual Healthcare Conference on Tuesday, July 13, 2021 at 4:30 pm ET.

Ra Medical Systems, Inc., a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces progress with finalizing the next-generation guidewire-compatible DABRA catheter design following a recent two-day, hands-on workshop with interventionalists who evaluated prototypes of the next-generation excimer laser catheter.

Zealand Pharma A/S a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, announced it will present three posters at the upcoming 17th Congress of the Intestinal Rehabilitation and Transplantation Association, which is being held both virtually and in Auckland, New Zealand June 30-July 2, 2021.

Appointments to be effective upon closing of the previously announced merger between Renovacor and Chardan Healthcare Acquisition 2 Corp.